NCT04409418

Brief Summary

The purpose of this study is to compare upper arm versus forearm Extended Dwell Catheter (EDC) placement for blood sampling functionality. EDC is an alternative to peripheral Intravenous (IVs) especially during prolonged hospital stays. EDCs are generally placed using ultrasound for guidance and are commonly placed in any of 3 veins in the arm. They can be inserted above or below the antecubital fossa (the bend of the elbow). These catheters can be left for up to 30 days and don't fail as quickly when compared to peripheral IVs.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 27, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 1, 2020

Completed
1.1 years until next milestone

Study Start

First participant enrolled

June 23, 2021

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2023

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

November 15, 2024

Completed
Last Updated

November 15, 2024

Status Verified

November 1, 2024

Enrollment Period

2.3 years

First QC Date

May 27, 2020

Results QC Date

September 18, 2024

Last Update Submit

November 12, 2024

Conditions

Keywords

intravenous accessvascular accessIV survival

Outcome Measures

Primary Outcomes (1)

  • Blood Sampling Functionality

    Blood sampling ability will be evaluated by daily blood draws prior to patient discharge. The measured outcome is number of hours until failure to aspirate blood identified during follow-up assessment during hospitalization.

    During hospitalization, up to 30 days

Secondary Outcomes (2)

  • Catheter Dwell Time/Survival

    During hospitalization, up to 30 days

  • Thrombosis

    During hospitalization, up to 30 days

Study Arms (2)

Experimental Group

EXPERIMENTAL

If the patient is randomized to the experimental group (lower arm), the research staff will direct the insert to place the catheter into the forearm at least 10 cm away from the antecubital fossa.

Device: Extended dwell catheters

Control Group

ACTIVE COMPARATOR

Control group (upper arm). If the patient is in the control group the research staff will direct the inserter to place the catheter into the upper arm vein at least 2 cm above the antecubital fossa.

Device: Extended dwell catheters

Interventions

EDCs are generally placed using ultrasound for guidance and are commonly placed in any of 3 veins in the arm. They can be inserted above or below the antecubital fossa (the bend of your elbow). These catheters can be left for up to 30 days and don't fail as quickly when compared to peripheral IVs.

Control GroupExperimental Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Consult to VAT for vascular access device placement
  • Patient requires peripheral access
  • Adults \>18 years of age
  • Age \> 18 years old
  • Difficult vascular access defined as: patient has no visible veins (\>2mm) or palpable veins
  • Anticipated hospital admission

You may not qualify if:

  • Patients will be excluded if:
  • Multiple lumens required
  • Functional vascular access device exists proximal to the targeted area of insertion. This does not include superficial non-ultrasound guided peripheral IVs.
  • Upper extremity cannot be accessed due to a coexisting medical condition
  • Cognitively impaired

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beaumont Hospital - Royal Oak

Royal Oak, Michigan, 48073, United States

Location

Results Point of Contact

Title
Dr. Amit Bahl
Organization
William Beaumont Hospitals

Study Officials

  • Amit Bahl, MD

    Corewell Health East

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Prospective, single-site, randomized
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director Emergency Medicine Ultrasound

Study Record Dates

First Submitted

May 27, 2020

First Posted

June 1, 2020

Study Start

June 23, 2021

Primary Completion

September 30, 2023

Study Completion

September 30, 2023

Last Updated

November 15, 2024

Results First Posted

November 15, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations